N4 Pharma Plc (N4P.L) Stock Price

£0.575 0%

Sign up
to add to portfolio

AI Score

Sell
  • Alternative

    2
  • Fundamental

    3
  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on N4 Pharma Plc, AI stock picks, stock alerts and much more.

Sign up

N4P.L AI Stock Analysis

AI stock analysis for N4P.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like N4 Pharma Plc (N4P.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

N4 Pharma Plc (N4P.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of N4 Pharma Plc (N4P.L), currently trading at £0.575, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About N4P.L

LSE
  • N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom.

  • Symbol

    N4P.L

  • Market

    LSE

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    2.2M

Similar Stocks

N4P.L Alternative Data

Web Traffic

N4 Pharma Plc receives an estimated 932 monthly visitors to n4pharma.com, which is down by -46.7% over the last month.

  • Web Traffic

    932

  • Change from Previous Month

    46.7%

  • 3 Month Change

    58.6%

News Mentions

N4 Pharma Plc was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

N4 Pharma Plc has 924 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.

  • Twitter Followers

    924

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1.3%

LinkedIn Followers

545 are following N4 Pharma Plc on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    545

  • Daily Change

    0%

  • 1 Month Change

    1.7%

  • 3 Month Change

    5%

LinkedIn Employees

According to LinkedIn, N4 Pharma Plc has 4 employees.

  • LinkedIn Employees

    4

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

N4P.L Financials

N4P.L Key Metrics
  • Total Revenue

    £3.9K

  • Net Income

    -£454.9K

  • Earnings per Share

    -£0.0016

  • Free cash flow

    -£390.9K

  • EBITDA

    -£491.7K

  • EBITDA Ratio

    -125.885

  • Total Assets

    £1.3M

N4P.L 2-year Revenue & Income
N4P.L 2-year Free Cash Flow

N4P.L Technicals

N4P.L SMA
N4P.L RSI

FAQ

What's the current price of N4 Pharma Plc (N4P.L) Stock?
The price of an N4 Pharma Plc (N4P.L) share is £0.575.

What's the market cap of N4 Pharma Plc?
The current market cap of N4 Pharma Plc is 2.2M.

Should I buy or sell N4P.L?
N4 Pharma Plc exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is N4 Pharma Plc a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in N4 Pharma Plc stock. There are several bearish signals and market challenges that could negatively impact N4 Pharma Plc's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy N4 Pharma Plc (N4P.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy N4 Pharma Plc stock right now, as the outlook appears bearish.

What are some stocks similar to N4 Pharma Plc (N4P.L) that investors often compare it to?
N4 Pharma Plc (N4P.L) is often compared to similar stocks such as Shield Therapeutics, Indivior PLC, Haleon plc, HUTCHMED (China) Limited and Hikma Pharmaceuticals PLC.

What is the forecast for N4 Pharma Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast N4 Pharma Plc's stock price to be around £0.532 in 2026. Starting from the current price of £0.575, this represents a 7.5% change in price, indicating a bearish outlook for the stock.

How to buy N4 Pharma Plc (N4P.L) Stock?
N4 Pharma Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy N4 Pharma Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.